Peter Greaves

4.5k total citations
78 papers, 2.7k citations indexed

About

Peter Greaves is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Peter Greaves has authored 78 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 13 papers in Oncology and 13 papers in Immunology. Recurrent topics in Peter Greaves's work include Estrogen and related hormone effects (7 papers), Immunotoxicology and immune responses (5 papers) and Sarcoma Diagnosis and Treatment (5 papers). Peter Greaves is often cited by papers focused on Estrogen and related hormone effects (7 papers), Immunotoxicology and immune responses (5 papers) and Sarcoma Diagnosis and Treatment (5 papers). Peter Greaves collaborates with scholars based in United Kingdom, United States and France. Peter Greaves's co-authors include Andreas J. Gescher, William P. Steward, Richard Edwards, Richard D. Verschoyle, Ian N.H. White, Graham R. Nunn, T.C. Orton, J.C. Topham, Andrew Williams and Malcolm D. Eve and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Nature Reviews Drug Discovery.

In The Last Decade

Peter Greaves

78 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Greaves United Kingdom 30 938 404 386 376 364 78 2.7k
Christoph Dorn Germany 33 1.2k 1.3× 582 1.4× 243 0.6× 313 0.8× 472 1.3× 125 3.9k
Pavel Uhrín Austria 30 1.8k 2.0× 505 1.3× 734 1.9× 498 1.3× 239 0.7× 70 4.7k
Xiaoning Wang China 35 1.4k 1.5× 248 0.6× 721 1.9× 338 0.9× 167 0.5× 120 3.4k
George Notas Greece 31 1.1k 1.1× 453 1.1× 534 1.4× 280 0.7× 491 1.3× 106 3.4k
Jian Liu China 28 1.4k 1.5× 381 0.9× 243 0.6× 665 1.8× 161 0.4× 271 3.2k
Mohamed M. Hafez Egypt 29 703 0.7× 252 0.6× 323 0.8× 202 0.5× 112 0.3× 99 2.5k
Karol Kajo Slovakia 25 1.0k 1.1× 142 0.4× 499 1.3× 499 1.3× 163 0.4× 134 2.6k
Tetsuo Kuroki Japan 34 887 0.9× 372 0.9× 408 1.1× 273 0.7× 428 1.2× 144 5.8k
Masuhiro Nishimura Japan 28 1.0k 1.1× 367 0.9× 996 2.6× 209 0.6× 338 0.9× 92 3.4k
Margie L. Clapper United States 34 1.9k 2.0× 181 0.4× 714 1.8× 577 1.5× 381 1.0× 95 3.2k

Countries citing papers authored by Peter Greaves

Since Specialization
Citations

This map shows the geographic impact of Peter Greaves's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Greaves with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Greaves more than expected).

Fields of papers citing papers by Peter Greaves

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Greaves. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Greaves. The network helps show where Peter Greaves may publish in the future.

Co-authorship network of co-authors of Peter Greaves

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Greaves. A scholar is included among the top collaborators of Peter Greaves based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Greaves. Peter Greaves is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yamada, Tomoya, Hiroyuki Asano, Kaori Miyata, et al.. (2019). Toxicological evaluation of carcinogenicity of the pyrethroid imiprothrin in rats and mice. Regulatory Toxicology and Pharmacology. 105. 1–14. 11 indexed citations
2.
Chernova, Tatyana, Fiona Murphy, Sara Galavotti, et al.. (2017). Long-Fiber Carbon Nanotubes Replicate Asbestos-Induced Mesothelioma with Disruption of the Tumor Suppressor Gene Cdkn2a ( Ink4a/Arf ). Current Biology. 27(21). 3302–3314.e6. 83 indexed citations
3.
James, Mark I., Chinenye Iwuji, Ankur Karmokar, et al.. (2015). Curcumin inhibits cancer stem cell phenotypes in ex vivo models of colorectal liver metastases, and is clinically safe and tolerable in combination with FOLFOX chemotherapy. Cancer Letters. 364(2). 135–141. 145 indexed citations
4.
Teichert, Friederike, Richard D. Verschoyle, Peter Greaves, et al.. (2010). Plasma metabolic profiling reveals age-dependency of systemic effects of green tea polyphenols in mice with and without prostate cancer. Molecular BioSystems. 6(10). 1911–1916. 3 indexed citations
5.
Verschoyle, Richard D., Peter Greaves, Ketan Patel, et al.. (2008). Evaluation of the cancer chemopreventive efficacy of silibinin in genetic mouse models of prostate and intestinal carcinogenesis: Relationship with silibinin levels. European Journal of Cancer. 44(6). 898–906. 37 indexed citations
6.
Teichert, Friederike, Richard D. Verschoyle, Peter Greaves, et al.. (2008). Metabolic profiling of transgenic adenocarcinoma of mouse prostate (TRAMP) Tissue by 1H‐NMR analysis: evidence for unusual phospholipid metabolism. The Prostate. 68(10). 1035–1047. 28 indexed citations
7.
Hardisty, Jerry F., Michael R. Elwell, Heinrich Ernst, et al.. (2007). Histopathology Of Hemangiosarcomas in Mice and Hamsters and Liposarcomas/Fibrosarcomas in Rats Associated with PPAR Agonists. Toxicologic Pathology. 35(7). 928–941. 32 indexed citations
8.
Verschoyle, Richard D., Peter Greaves, Hong Cai, et al.. (2007). Evaluation of the cancer chemopreventive efficacy of rice bran in genetic mouse models of breast, prostate and intestinal carcinogenesis. British Journal of Cancer. 96(2). 248–254. 58 indexed citations
9.
Greaves, Peter, Bruce Clothier, Reginald Davies, et al.. (2005). Uroporphyria and hepatic carcinogenesis induced by polychlorinated biphenyls–iron interaction: Absence in the Cyp1a2(−/−) knockout mouse. Biochemical and Biophysical Research Communications. 331(1). 147–152. 7 indexed citations
10.
Cai, Hong, E A Hudson, Richard D. Verschoyle, et al.. (2004). Growth-inhibitory and cell cycle-arresting properties of the rice bran constituent tricin in human-derived breast cancer cells in vitro and in nude mice in vivo. British Journal of Cancer. 91(7). 1364–1371. 81 indexed citations
11.
Donald, Sarah, Richard D. Verschoyle, Peter Greaves, et al.. (2004). Comparison of four modulators of drug metabolism as protectants against the hepatotoxicity of the novel antitumor drug yondelis (ET-743) in the female rat and in hepatocytes in vitro. Cancer Chemotherapy and Pharmacology. 53(4). 305–312. 15 indexed citations
12.
Greaves, Peter, Andrew Williams, & Malcolm D. Eve. (2004). First dose of potential new medicines to humans: how animals help. Nature Reviews Drug Discovery. 3(3). 226–236. 146 indexed citations
13.
14.
Green, Andrew R., et al.. (2001). Comparisons of the effects of tamoxifen, toremifene and raloxifene on enzyme induction and gene expression in the ovariectomised rat uterus. Journal of Endocrinology. 170(3). 555–564. 12 indexed citations
15.
Greaves, Peter. (2000). Patterns of cardiovascular pathology induced by diverse cardioactive drugs. Toxicology Letters. 112-113. 547–552. 13 indexed citations
16.
Greaves, Peter, et al.. (1993). Two-year carcinogenicity study of tamoxifen in Alderley Park Wistar-derived rats.. PubMed. 53(17). 3919–24. 249 indexed citations
17.
Greaves, Peter, et al.. (1987). Periarteritis in a beagle colony. Journal of Comparative Pathology. 97(2). 121–128. 23 indexed citations
18.
19.
Andreu, M., et al.. (1986). Neoplasia and Hyperplasia of Pancreatic Endocrine Tissue in the Rat: An Immunocytochemical Study. Veterinary Pathology. 23(1). 11–15. 18 indexed citations
20.
Greaves, Peter, M. I. Filipe, & A.C. Branfoot. (1980). Transitional mucosa and survival in human colorectal cancer. Cancer. 46(4). 764–770. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christoph Dorn Breakdown of academic impact, for papers by Pavel Uhrín Breakdown of academic impact, for papers by Xiaoning Wang Breakdown of academic impact, for papers by George Notas Breakdown of academic impact, for papers by Jian Liu Breakdown of academic impact, for papers by Mohamed M. Hafez Breakdown of academic impact, for papers by Karol Kajo Breakdown of academic impact, for papers by Tetsuo Kuroki Breakdown of academic impact, for papers by Masuhiro Nishimura Breakdown of academic impact, for papers by Margie L. Clapper
Rankless by CCL
2026